Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate
(23)
- Computing and Computational Sciences Directorate (35)
- Energy Science and Technology Directorate (217)
- Fusion and Fission Energy and Science Directorate (21)
- Information Technology Services Directorate (2)
- Isotope Science and Enrichment Directorate (6)
- National Security Sciences Directorate (17)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (128)
- User Facilities (27)
Researcher
- Andrzej Nycz
- Chris Masuo
- Luke Meyer
- William Carter
- Alexander I Wiechert
- Alex Walters
- Benjamin Manard
- Brian Sanders
- Bruce Hannan
- Charles F Weber
- Costas Tsouris
- Derek Dwyer
- Gerald Tuskan
- Ilenne Del Valle Kessra
- Jerry Parks
- Joanna Mcfarlane
- Jonathan Willocks
- Joshua Vaughan
- Loren L Funk
- Louise G Evans
- Matt Vick
- Mengdawn Cheng
- Paul Abraham
- Paula Cable-Dunlap
- Peter Wang
- Polad Shikhaliev
- Richard L. Reed
- Theodore Visscher
- Vandana Rallabandi
- Vilmos Kertesz
- Vladislav N Sedov
- Xiaohan Yang
- Yacouba Diawara
- Yang Liu

High-gradient magnetic filtration (HGMF) is a non-destructive separation technique that captures magnetic constituents from a matrix containing other non-magnetic species. One characteristic that actinide metals share across much of the group is that they are magnetic.

ORNL has developed a large area thermal neutron detector based on 6LiF/ZnS(Ag) scintillator coupled with wavelength shifting fibers. The detector uses resistive charge divider-based position encoding.

Pyrolysis evolved gas analysis – mass spectrometry (EGA-MS) and pyrolysis gas chromatography – MS (GC-MS) – are powerful analytical tools for polymer characterization.

Detection of gene expression in plants is critical for understanding the molecular basis of plant physiology and plant responses to drought, stress, climate change, microbes, insects and other factors.

We have developed an aerosol sampling technique to enable collection of trace materials such as actinides in the atmosphere.

Direct-acting antivirals are needed to combat coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

There is a critical need for new antiviral drugs for treating infections of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).